Re-shoring Manufacturing Will Strengthen Drug Supply Chains In France
Pharmaceuticals / France / Fri 23 Jun, 2023
Key View
- Re-shoring of pharmaceutical manufacturing to France will improve supply chain resilience in the long term.
- However, drug shortages in France will persist in the short-to-medium term due to the considerable time required for infrastructure development and the reorientation of supply chains
- We expect companies in Western Europe to